期刊文献+

基于数据挖掘分析魏军平教授治疗Graves病的用药规律

Analysis on Professor Wei Junping′s Medication Experience for Graves Disease Based on Data Mining Methods
下载PDF
导出
摘要 目的:探讨魏军平教授治疗Graves病的处方用药规律。方法:收集整理魏军平教授Graves病的门诊处方203张,构建处方数据库,应用相关软件,分析处方中药物的关联性。结果:对选出的203个处方进行统计,涉及141味中药,确定处方中药物的使用频次和药物之间的关联规则,其中使用频次高于40的中药共20味,前5位中药依次为夏枯草、柴胡、白术、茯苓、白芍,并挖掘出16个核心组合和9首新处方。结论:魏军平教授治疗Graves Graves病治则治法的用药原则。 Objective: To analyze the medication experience of Professor Wei We collected the prescriptions used for Graves disease cases at Professor Wei establish the prescriptions formula database,application related software to analyze the association of drugs in prescriptions.Results: Statistics on the selected 203 prescriptions included,refer to 141 herbs.Summarize the frequency of use of the drug in the prescription and the rules of association between the drugs.A total of 20 herbs had a frequency of more than 40,and top 5 herbs with high using frequency were Prunella,Bupleurum,Atractylodes,Poria,Radix Paeoniae Alba,and 16 groups of core herbs combinations and 11 new prescriptions were developed.Conclusion: Professor Wei has a wealth of experience in treating Graves disease.Professor Wei is good at dredge the liver to relieve the depression,obliterate the anger of the liver,replenishing the vital essence and removing heat,invigorating spleen to eliminate phlegm and resolving hard lump.It is in line with the principle of Professor Wei’s medication for the treatment of Graves’ disease.
作者 李菲 郑慧娟 柏力萄 赵静 魏军平 Li Fei;Zheng Huijuan;Bai Litao;Zhao Jing;Wei Junping(Guang'anmen Hospital of China Academy of Chinese Medical Sciences,Beijing 100053,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2019年第2期272-277,共6页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 中国中医科学院中央级公益性科研院所基本科研业务专项资金(ZZ11-030):疏肝健脾化痰行气方干预亚临床甲减多中心随机对照临床研究 负责人:魏军平 国家自然科学基金委面上基金项目(81573961):基于自噬在M22诱导甲状腺细胞增殖中的作用探讨中药甲亢宁治疗Graves病的机制 负责人:魏军平
关键词 GRAVES病 数据挖掘 关联规则 用药规律 Graves disease data mining association rules medication rules
  • 相关文献

二级参考文献31

  • 1姚政,陶枫,丁学屏.灵异胶囊治疗糖尿病周围神经病变临床观察[J].上海中医药杂志,2005,39(8):21-22. 被引量:7
  • 2刘娟,蒋永光,任玉兰,韩佩玉.关联规则在中药药对挖掘中的应用[J].时珍国医国药,2006,17(4):492-493. 被引量:31
  • 3Bahn Chair RS,Burch HB,Cooper DS,et al.Hyperthyroidism and other causes of thyrotoxicosis:management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J].Thyroid,2011,21(6):593-646.
  • 4George J.Kahaly,Luigi Bartalena,et al.The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis:a European perspective[J].Thyroid,2011,21(6):585-591.
  • 5Yamashita S,Amino N,Shong YK.The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines:viewpoints from Japan and Korea[J].Thyroid,2011,21(6):577-580.
  • 6Cooper DS,Doherty GM,Haugen BR,et al.American Thyroid Association(ATA)Guidelines Taskforce on thyroid nodules and differentiated cancer[J].Thyroid,2009,19(11)1167-1214.
  • 7Trdisk F,Tallstedt L,Abraham-Nordling M,et al.Thyroidassociated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131[J].J Clin Endocrinol Metab,2009,94(10):3700-3707.
  • 8Peters H,Fischer C,Bogner U,et al.Radioiodine therapy of Graves' hyperthyroidism:standard vs.calculated 131 iodine activity.Results from aprospective,randomized,multicentre study[J].Eur J Clin Invest,1995,25(3):186-193.
  • 9Costaghola S,Morgenthaler NG,Hoermann R,et al.Second generation assay for thyrotropin receptor antibodies has superior diagnostics ensitivity for Graves' disease[J].J Clin Endocrinol Metab,1999,84(1):90-97.
  • 10Cooper DS.Antithyroid drugs[J].N Engl J Med,2005,352(9):905-917.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部